ResMed | RMD - 销售和管理费用

金融业

USD 239.77

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 35.15B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	销售和管理费用	更改		日
Ansell	USD 274.8M		7.6M	2025-12
Artivion	USD 55.75M		4.54M	2025-12
AtriCure	USD 82.56M		1.99M	2026-06
Baxter International	USD 735M		7M	2026-06
Cochlear	AUD 449.4M		214.45M	2025-12
Cooper Companies	USD 401.3M		274.9M	2026-06
CSL	USD 1.23B		498M	2025-12
Dexcom	USD 358.7M		9M	2026-06
Edwards Lifesciences	USD 561.2M		39M	2026-06
Fisher Paykel Healthcare	NZD 312.7M		27.2M	2026-06
Globus Medical	USD 286.82M		10.95M	2026-06
Haemonetics	USD 118.94M		1.99M	2026-06
Idexx Laboratories	USD 288.09M		11.76M	2026-06
Inogen	USD 43.77M		510K	2024-06
Insulet	USD 344.8M		27.6M	2026-06
Integra LifeSciences	USD 166.22M		12.01M	2026-06
Intuitive Surgical	USD 617.9M		4.6M	2026-06
Medtronic	3.2B		141M	2026-06
Philips	EUR 1.21B		23M	2026-06
Ramsay Health Care	AUD 5.29B		3.2M	2024-12
ResMed	USD 290.65M		10.86M	2026-06
Sigma Healthcare	AUD 134.77M		9.73M	2024-12
Sonic Healthcare	AUD 2.52B		2.46B	2024-12
Steris	USD 369.7M		17.9M	2026-06
Teleflex	USD 213.52M		12.5M	2026-06
Thermo Fisher Scientific	USD 1.91B		111M	2026-06